SHP Wealth Management’s ResMed RMD Stock Holding History

SHP Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.18K	Buy	32 +28	+700%	+$6.98K	﹤0.01%	983
2025 Q4	$964	Buy	+4	New	+$1.02K	﹤0.01%	1265

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SHP Wealth Management's RMD Position: Q1 2026 in Review

SHP Wealth Management increased its ResMed (RMD) stake by 700% in Q1 2026, buying an estimated $6.98K and bringing the position to 32 shares worth $7.18K. The position accounts for ﹤0.01% of the portfolio, ranked #983.

SHP Wealth Management first reported a position in RMD in Q4 2025 and has held it in 2 quarters since. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

SHP Wealth Management held 32 shares of ResMed worth $7.18K as of Q1 2026.
SHP Wealth Management bought 28 ResMed shares in Q1 2026, an estimated $6.98K.
ResMed made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #983 holding.
SHP Wealth Management first reported a position in ResMed in Q4 2025 and has held it in 2 quarters since.
940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.